Wanderling, Christopher <br/><br/>
Dysregulation of Tissue Factor, Thrombin-Activatable Fibrinolysis Inhibitor, and Fibrinogen in Patients Undergoing Total Joint Arthroplasty.  [electronic resource] 

 -  Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis  Nov 2017 
 - 967-972 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1938-2723 
<br/><br/><label>Standard No.: </label>10.1177/1076029617700998  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Arthroplasty, Replacement, Hip--adverse effects<br/>Biomarkers<br/>Carboxypeptidase B2--blood<br/>Female<br/>Fibrinogen--metabolism<br/>Humans<br/>Male<br/>Middle Aged<br/>Thromboplastin--metabolism<br/>Venous Thrombosis--blood